Tag: hangover cures

  • The Safety of Milk Thistle

    A few months ago, founder Mike McAdams of Drinkwel reached out to me. This product is meant to be a vitamin for drinkers rather than just a hangover cure.

    I told them that I was unsure about one of the ingredients in the mixture, milk thistle, as I'd heard reports that rather than being good for the liver it may actually cause harm.  

    This caused a conversation that I thought I'd share. McAdams replied:

    It's also funny you mention milk thistle because that was really our only ingredient that had an interaction paper on it. I've taken it on and off for a couple years but make sure my dosages are not too high. 

    In case you're interested, here is what our doctor who helped formulate had to say (unfiltered): 

    Milk thistle is probably the most well known liver protectant on the market. As far as alcohol intake, new studies have shown that milk thistle has both liver toxicity protection from ethanol [18] and protects against liver fibrosis in non-human primates [19]. 

    Safety

    There is the possibility of an adverse reaction with milk thistle (possible Pk interactions regarding the decrease of CYP, UGT, and P-Gp activity) [20]. These decreases seem limited so should not be a concern. Therefore, I believe this drug to be a safe and positive addition to the formulation.

    and:

    The biggest concern would be Milk thistle with only one interaction paper. I think for the most part its use in this formulation would be fine. It has been used for this type of treatment for numerous years without a major side effect case report being brought to light.

    18.       Song, Z., et al., Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcohol Clin Exp Res, 2006. 30(3): p. 407-13.

    19.       Lieber, C.S., et al., Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol, 2003. 37(4): p. 336-9.

    20.       Wu, J.W., L.C. Lin, and T.H. Tsai, Drug-drug interactions of silymarin on the perspective of pharmacokinetics. J Ethnopharmacol, 2009. 121(2): p. 185-93.

    I followed up with McAdams and he send some more information. Then I followed up with the National Institutes of Health. This is all below the jump. 

    (more…)